Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network

Author:

Makadia Rupa12,Shoaibi Azza12,Rao Gowtham A12,Ostropolets Anna13ORCID,Rijnbeek Peter R14,Voss Erica A12ORCID,Duarte-Salles Talita15ORCID,Ramírez-Anguita Juan Manuel6,Mayer Miguel A7,Maljković Filip8,Denaxas Spiros910ORCID,Nyberg Fredrik11ORCID,Papez Vaclav9ORCID,Sena Anthony G124ORCID,Alshammari Thamir M112,Lai Lana Y H113,Haynes Kevin2,Suchard Marc A114ORCID,Hripcsak George13,Ryan Patrick B123

Affiliation:

1. OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI) , New York, NY 10027, United States

2. Global Epidemiology, Janssen Pharmaceutical Research and Development, LLC , Titusville, NJ 08560, United States

3. Department of Biomedical Informatics, Columbia University Irving Medical Center , New York, NY 10027, United States

4. Department of Medical Informatics, Erasmus University Medical Center , Rotterdam, 3000 CA, The Netherlands

5. Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) , Barcelona, 08007, Spain

6. Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM) , Barcelona, 08003, Spain

7. Management Control Department, Parc de Salut Mar (PSMAR) , Barcelona, 08007, Spain

8. Research and Development, Heliant d.o.o , Belgrade, 11000, Serbia

9. Institute of Health Informatics, University College London , London, NW1 2DA, United Kingdom

10. British Heart Foundation Data Science Centre, HDR , London, NW1 2DA, United Kingdom

11. School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg, 40530, Sweden

12. College of Pharmacy, Prince Sattam Bin Abdulaziz University , Riyadh, 11942, Saudi Arabia

13. Division of Informatics, Imaging and Data Sciences, University of Manchester , Manchester, M13 9PL, United Kingdom

14. Department of Biostatistics, University of California, Los Angeles , Los Angeles, CA 90025, United States

Abstract

Abstract Objective Developing accurate phenotype definitions is critical in obtaining reliable and reproducible background rates in safety research. This study aims to illustrate the differences in background incidence rates by comparing definitions for a given outcome. Materials and Methods We used 16 data sources to systematically generate and evaluate outcomes for 13 adverse events and their overall background rates. We examined the effect of different modifications (inpatient setting, standardization of code set, and code set changes) to the computable phenotype on background incidence rates. Results Rate ratios (RRs) of the incidence rates from each computable phenotype definition varied across outcomes, with inpatient restriction showing the highest variation from 1 to 11.93. Standardization of code set RRs ranges from 1 to 1.64, and code set changes range from 1 to 2.52. Discussion The modification that has the highest impact is requiring inpatient place of service, leading to at least a 2-fold higher incidence rate in the base definition. Standardization showed almost no change when using source code variations. The strength of the effect in the inpatient restriction is highly dependent on the outcome. Changing definitions from broad to narrow showed the most variability by age/gender/database across phenotypes and less than a 2-fold increase in rate compared to the base definition. Conclusion Characterization of outcomes across a network of databases yields insights into sensitivity and specificity trade-offs when definitions are altered. Outcomes should be thoroughly evaluated prior to use for background rates for their plausibility for use across a global network.

Funder

European Union’s Horizon 2020

European Health Data & Evidence Network

Instituto de Salud Carlos III

Publisher

Oxford University Press (OUP)

Subject

Health Informatics

Reference18 articles.

1. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines;Black;Lancet,2009

2. A framework to support the sharing and reuse of computable phenotype definitions across health care delivery and clinical research applications;Richesson;EGEMS (Wash DC),2016

3. Assessing the safety of COVID-19 vaccines: a primer;Petousis-Harris;Drug Saf,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3